(Q34892334)

5 August 2017

6 references

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

26 September 2020

0 references

Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis (English)

1 reference

bacterial infectious disease

5 August 2017

main subject

6 references

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

26 September 2020

heterocyclic compound

1 reference

17 September 2019

1 reference

7 November 2019

1 reference

11 September 2020

1 reference

piperacillin/tazobactam

1 reference

1 reference

Hui Yang

1

1 reference

5 August 2017

Chao Zhang

2

1 reference

5 August 2017

Quanyu Zhou

3

1 reference

5 August 2017

Yike Wang

4

1 reference

5 August 2017

Lujia Chen

5

1 reference

5 August 2017

language of work or name

English

0 references

publication date

9 January 2015

7 references

5 August 2017

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

26 September 2020

7 references

5 August 2017

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

26 September 2020

10

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

e0116769

1 reference

Creative Commons Attribution 4.0 International

5 August 2017

copyright license

6 references

23 March 2019

22 June 2019

17 September 2019

7 November 2019

11 September 2020

on focus list of Wikimedia project

26 September 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Continuous infusion of piperacillin/tazobactam in septic critically ill patients--a multicenter propensity matched analysis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parameters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Transformation of isolated mammalian mitochondria by bacterial conjugation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Continuous infusion versus intermittent administration of meropenem in critically ill patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Bias in meta-analysis detected by a simple, graphical test

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Piperacillin/tazobactam in treatment of brain abscess

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

The Use of Fixed-and Random-Effects Models for Classifying Hospitals as Mortality Outliers: A Monte Carlo Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

A high content screening assay to predict human drug-induced liver injury during drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

Development and implementation of a piperacillin-tazobactam extended infusion guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0116769

[Treatment study of hospital acquired pneumonia by optimizing dosing regimen of piperacillin/tazobactam:prolonged vs. regular infusion].

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Fixed or random testlet effects: a comparison of two multilevel testlet models.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289069

Critical appraisal. 5. Randomised controlled trials: questions for valid evidence

26 October 2018

1 reference

12 December 2020

Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models

1 reference

12 December 2020

Prevention of resistance: a goal for dose selection for antimicrobial agents

1 reference

12 December 2020

Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection

1 reference

12 December 2020

Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients

1 reference

12 December 2020

Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy

1 reference

12 December 2020

Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0116769

Identifiers

DOI

1 reference

5 August 2017

0 references

1 reference

5 August 2017

1 reference